Yuhan Corporation
Records under this name other than the patents Yuhan Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 61 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,981,658 | Substituted Aminopyridine Compounds as Egfr Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 12,258,328 | 6-Membered Heteroaryl-Containing Aminopyridine Compounds as Egfr Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 10,130,611 | Use of Benzo-Heterocycle Derivatives for Preventing and Treating Cancer or for Inhibiting Cancer Metastasis Formerly held Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 11,091,479 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same Lapsed on the fee record Ended Aug 17, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | USPTO record |
| US 9,593,098 | Compounds and Compositions for Modulating Egfr Mutant Kinase Activities Surrendered on reissue Surrendered on reissue Aug 12, 2025 · High confidence | Surrendered on reissue | Surrendered on reissue Aug 12, 2025 | High confidence |
| US 10,899,719 | Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same Lapsed on the fee record Ended Jan 26, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 26, 2025 | USPTO record |
| US 7,220,861 | Processes for preparing quinolonecarboxylate derivatives Term ended Term ended Apr 23, 2024 · USPTO record | Term ended | Term ended Apr 23, 2024 | USPTO record |
| US 7,915,383 | Method of separating a peptidoglycan recognition protein from a hemolymph Tenebrio molitor larvae Lapsed on the fee record Ended Mar 29, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 29, 2023 | USPTO record |
| US 6,660,854 | Processes for preparing &bgr;-D-ribofuranose derivatives Term ended Term ended Dec 6, 2022 · USPTO record | Term ended | Term ended Dec 6, 2022 | USPTO record |
| US 8,729,230 | Proteins activating pro-phenoloxidase system and genes encoding the same Lapsed on the fee record Ended May 20, 2022 · USPTO record | Lapsed on the fee record | Ended May 20, 2022 | USPTO record |